Risposta immunitaria diretta contro antigeni epatici in pazienti con deficit di alpha 1-antitripsina.

Translated title of the contribution: Direct immune response against hepatic antigens in patients with alpha-1-antitrypsin deficiency

P. Grossi, S. Dughetti, G. Di Perri, S. Vento, M. Mondelli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

We have investigated the possible role of cell-mediated immunity in the pathogenesis of liver disease associated with alpha 1-antitrypsin (AAT) deficiency in 16 children with PiZZ phenotype, who presented with liver disease in infancy. Peripheral blood lymphocytes from 13 patients were incubated with autologous hepatocytes in a microcytotoxicity assay. There was a clear trend for cytotoxicity to increase with age and thus significantly increased cytotoxicity was found in four cases older than 2 years, while intermediate values were recorded in three children between 6 months and 2 years and normal values in children younger than 6 months. Fractionation of PBL into T and non-T-enriched subsets showed that both were involved in the cytotoxic reaction. A purified liver membrane lipoprotein preparation (LSP) inhibited both T and non-T-cell cytotoxicity suggesting that LSP is a major target antigen in this system. Sensitization to LSP was also present in 2 of the 3 children studied using a recently developed T-lymphocyte migration inhibitory factor (T-LIF) test. Control experiments performed in infants with neonatal hepatitis syndrome, but with normal Pi phenotype showed consistently increased cytotoxicity values. Cell-mediated immune reactions directed against autologous hepatocytes develop late in the course of the liver disease associated with AAT deficiency. While this reaction cannot be involved in the pathogenesis of the initial liver lesion, it may contribute to perpetuation of liver damage.

Original languageItalian
Pages (from-to)143-149
Number of pages7
JournalBollettino dell"Istituto sieroterapico milanese
Volume65
Issue number2
Publication statusPublished - 1986
Externally publishedYes

Fingerprint

alpha 1-Antitrypsin Deficiency
Antigens
Liver Diseases
Liver
Hepatocytes
Phenotype
Cellular Immunity
Hepatitis
Lipoproteins
Reference Values
Lymphocytes
T-Lymphocytes
Membranes
Autosomal Recessive alpha-1-Antitrypsin Deficiency

ASJC Scopus subject areas

  • Immunology

Cite this

Risposta immunitaria diretta contro antigeni epatici in pazienti con deficit di alpha 1-antitripsina. / Grossi, P.; Dughetti, S.; Di Perri, G.; Vento, S.; Mondelli, M.

In: Bollettino dell"Istituto sieroterapico milanese, Vol. 65, No. 2, 1986, p. 143-149.

Research output: Contribution to journalArticle

@article{2f4362f0c8da4053af87dafb64a7d86f,
title = "Risposta immunitaria diretta contro antigeni epatici in pazienti con deficit di alpha 1-antitripsina.",
abstract = "We have investigated the possible role of cell-mediated immunity in the pathogenesis of liver disease associated with alpha 1-antitrypsin (AAT) deficiency in 16 children with PiZZ phenotype, who presented with liver disease in infancy. Peripheral blood lymphocytes from 13 patients were incubated with autologous hepatocytes in a microcytotoxicity assay. There was a clear trend for cytotoxicity to increase with age and thus significantly increased cytotoxicity was found in four cases older than 2 years, while intermediate values were recorded in three children between 6 months and 2 years and normal values in children younger than 6 months. Fractionation of PBL into T and non-T-enriched subsets showed that both were involved in the cytotoxic reaction. A purified liver membrane lipoprotein preparation (LSP) inhibited both T and non-T-cell cytotoxicity suggesting that LSP is a major target antigen in this system. Sensitization to LSP was also present in 2 of the 3 children studied using a recently developed T-lymphocyte migration inhibitory factor (T-LIF) test. Control experiments performed in infants with neonatal hepatitis syndrome, but with normal Pi phenotype showed consistently increased cytotoxicity values. Cell-mediated immune reactions directed against autologous hepatocytes develop late in the course of the liver disease associated with AAT deficiency. While this reaction cannot be involved in the pathogenesis of the initial liver lesion, it may contribute to perpetuation of liver damage.",
author = "P. Grossi and S. Dughetti and {Di Perri}, G. and S. Vento and M. Mondelli",
year = "1986",
language = "Italian",
volume = "65",
pages = "143--149",
journal = "Bollettino dell{"}Istituto sieroterapico milanese",
issn = "0021-2547",
number = "2",

}

TY - JOUR

T1 - Risposta immunitaria diretta contro antigeni epatici in pazienti con deficit di alpha 1-antitripsina.

AU - Grossi, P.

AU - Dughetti, S.

AU - Di Perri, G.

AU - Vento, S.

AU - Mondelli, M.

PY - 1986

Y1 - 1986

N2 - We have investigated the possible role of cell-mediated immunity in the pathogenesis of liver disease associated with alpha 1-antitrypsin (AAT) deficiency in 16 children with PiZZ phenotype, who presented with liver disease in infancy. Peripheral blood lymphocytes from 13 patients were incubated with autologous hepatocytes in a microcytotoxicity assay. There was a clear trend for cytotoxicity to increase with age and thus significantly increased cytotoxicity was found in four cases older than 2 years, while intermediate values were recorded in three children between 6 months and 2 years and normal values in children younger than 6 months. Fractionation of PBL into T and non-T-enriched subsets showed that both were involved in the cytotoxic reaction. A purified liver membrane lipoprotein preparation (LSP) inhibited both T and non-T-cell cytotoxicity suggesting that LSP is a major target antigen in this system. Sensitization to LSP was also present in 2 of the 3 children studied using a recently developed T-lymphocyte migration inhibitory factor (T-LIF) test. Control experiments performed in infants with neonatal hepatitis syndrome, but with normal Pi phenotype showed consistently increased cytotoxicity values. Cell-mediated immune reactions directed against autologous hepatocytes develop late in the course of the liver disease associated with AAT deficiency. While this reaction cannot be involved in the pathogenesis of the initial liver lesion, it may contribute to perpetuation of liver damage.

AB - We have investigated the possible role of cell-mediated immunity in the pathogenesis of liver disease associated with alpha 1-antitrypsin (AAT) deficiency in 16 children with PiZZ phenotype, who presented with liver disease in infancy. Peripheral blood lymphocytes from 13 patients were incubated with autologous hepatocytes in a microcytotoxicity assay. There was a clear trend for cytotoxicity to increase with age and thus significantly increased cytotoxicity was found in four cases older than 2 years, while intermediate values were recorded in three children between 6 months and 2 years and normal values in children younger than 6 months. Fractionation of PBL into T and non-T-enriched subsets showed that both were involved in the cytotoxic reaction. A purified liver membrane lipoprotein preparation (LSP) inhibited both T and non-T-cell cytotoxicity suggesting that LSP is a major target antigen in this system. Sensitization to LSP was also present in 2 of the 3 children studied using a recently developed T-lymphocyte migration inhibitory factor (T-LIF) test. Control experiments performed in infants with neonatal hepatitis syndrome, but with normal Pi phenotype showed consistently increased cytotoxicity values. Cell-mediated immune reactions directed against autologous hepatocytes develop late in the course of the liver disease associated with AAT deficiency. While this reaction cannot be involved in the pathogenesis of the initial liver lesion, it may contribute to perpetuation of liver damage.

UR - http://www.scopus.com/inward/record.url?scp=0022438213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022438213&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 143

EP - 149

JO - Bollettino dell"Istituto sieroterapico milanese

JF - Bollettino dell"Istituto sieroterapico milanese

SN - 0021-2547

IS - 2

ER -